Overview

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

Status:
COMPLETED

Trial end date:
2025-05-01

Target enrollment:

Participant gender:

Summary

This study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 different doses of NNC0519-0130. Participants will take 1-2 injections once a week. The study medicine will be injected under skin with a thin needle in the stomach, thigh, or upper arm. The study will last for about 42 weeks.

Phase:

PHASE2

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Tirzepatide